comparemela.com

Latest Breaking News On - First mercantile trust co - Page 31 : comparemela.com

Dollar General (NYSE:DG) PT Lowered to $230 00 at Deutsche Bank Aktiengesellschaft

Dollar General (NYSE:DG – Get Rating) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $251.00 to $230.00 in a research report report published on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock. DG has been the subject of several other reports. Morgan Stanley downgraded Dollar General […]

First Mercantile Trust Co Sells 1,019 Shares of Amedisys, Inc (NASDAQ:AMED)

First Mercantile Trust Co. lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 52.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 937 shares of the health services provider’s stock after selling 1,019 shares during the […]

First Mercantile Trust Co Grows Stock Position in Intellia Therapeutics, Inc (NASDAQ:NTLA)

First Mercantile Trust Co. raised its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Rating) by 65.4% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 827 shares of the company’s stock after buying an additional 327 shares during the period. First Mercantile Trust Co.’s […]

First Mercantile Trust Co Invests $118,000 in GXO Logistics Inc (NYSE:GXO)

First Mercantile Trust Co. acquired a new position in GXO Logistics Inc (NYSE:GXO – Get Rating) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 1,503 shares of the company’s stock, valued at approximately $118,000. Several other institutional investors and hedge funds […]

First Mercantile Trust Co Buys New Holdings in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN)

First Mercantile Trust Co. bought a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 208 shares of the biopharmaceutical company’s stock, valued at approximately $126,000. Several other hedge funds and other […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.